NCT04248478

Brief Summary

The Relationship Between Eating Behaviours and Health Status of Female Patients with Fibromyalgia

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

January 29, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 30, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

May 5, 2020

Status Verified

May 1, 2020

Enrollment Period

4 months

First QC Date

January 28, 2020

Last Update Submit

May 3, 2020

Conditions

Keywords

Chronic PainEating Habits

Outcome Measures

Primary Outcomes (1)

  • eating behaviour

    Participants' eating behaviour will be questioned with Three Factor Eating Questionnaire (TFEQ). The TFEQ contains 51 items (questions) and measures three dimensions of human eating behavior 'cognitive restraint of eating' (Factor I - 21 items) 'disinhibition' (Factor II - 16 items) 'hunger' (Factor III - 14 items). Each item scores either 0 or 1 point. The minimum score for factors I-II-III is therefore 0-0-0, the possible maximum score 21-16-14.

    7 days

Secondary Outcomes (7)

  • activities of daily living

    7 days

  • body mass index

    1 day

  • sex

    1 day

  • age

    1 day

  • level of education

    1 day

  • +2 more secondary outcomes

Study Arms (2)

Fibromiyalgia Patients

Patients diagnosed with fibromyalgia according to 2013 American College of Rheumatology criteria are planned to be included in this arm.

Other: Eating BehavioursOther: Health Status

Healthy Volunteers

Healthy volunteers are planned to be included in this arm.

Other: Eating Behaviours

Interventions

Patients' eating behaviour will be questioned with Three Factor Eating Questionnaire. The 18-item Three-Factor Eating Questionnaire is a scale that measures three domains of eating behavior: cognitive restraint , uncontrolled eating and emotional eating.

Fibromiyalgia PatientsHealthy Volunteers

The effect of fibromyalgia on the daily life of the patients will be questioned with Fibromyalgia Impact Questionnaire (FIQ). The FIQ was developed from information gathered from patient reports, functional status instruments, and clinical observations. This instrument measures physical functioning, work status (missed days of work and job difficulty), depression, anxiety, morning tiredness, pain, stiffness, fatigue, and well-being over the past week.

Fibromiyalgia Patients

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with fibromyalgia and healthy volunteers are planned to be included in the study.

You may qualify if:

  • Female patients between the ages of 18-40
  • Patients diagnosing fibromyalgia for the first time according by 2013 American College of Rheumatology (ACR) criteria

You may not qualify if:

  • History of eating disorders such as anorexia nervosa, bulimia nevroza
  • History of hypothyroidism or hyperthyroidism
  • Pregnant or breast feeding
  • History of central or peripheral nervous system disorders
  • History of infectious, chronic inflammatory disease, malignant tumors
  • Subjects with active psychiatric illness or who use psychiatric medication
  • Uncooperative subject
  • History of cardiac pathology such as heart failure, coronary artery disease
  • History of diabetes, chronic renal insufficiency, chronic liver failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alper Mengi

Çanakkale, 17100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Feeding BehaviorFibromyalgiaChronic Pain

Interventions

Health Status

Condition Hierarchy (Ancestors)

Behavior, AnimalBehaviorMuscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DemographyPopulation CharacteristicsEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Alper Mengi, M.D.

    Canakkale State Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alper Mengi, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Physiatrist

Study Record Dates

First Submitted

January 28, 2020

First Posted

January 30, 2020

Study Start

January 29, 2020

Primary Completion

June 1, 2020

Study Completion

June 1, 2020

Last Updated

May 5, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations